151. Is Pepsin a Reliable Marker of Laryngopharyngeal Reflux? A Systematic Review
- Author
-
Alberto Ruano-Ravina, Christian Calvo-Henriquez, Carlos Martin-Martin, Gabriel Martínez-Capoccioni, and Pedro Vaamonde
- Subjects
medicine.medical_specialty ,Web of science ,MEDLINE ,Cochrane Library ,Gastroenterology ,03 medical and health sciences ,Laryngopharyngeal reflux ,0302 clinical medicine ,Pepsin A ,Pepsin ,Internal medicine ,Laryngopharyngeal Reflux ,medicine ,Humans ,Saliva ,030223 otorhinolaryngology ,biology ,business.industry ,Reflux ,Reproducibility of Results ,medicine.disease ,Otorhinolaryngology ,biology.protein ,030211 gastroenterology & hepatology ,Surgery ,business ,Biomarkers - Abstract
Objective Laryngopharyngeal reflux (LPR) is a common illness of otolaryngology visits. Over the past few years, pepsin has become a promising marker of LPR. The objective of the present research is to analyze the existing literature using pepsin as a diagnostic tool of LPR through a systematic review. Data Sources PubMed (Medline), Trip Database, Cochrane Library, EMBASE, SUMsearch, and Web of Science. Review Methods The outcome assessed was the presence of pepsin in LPR patients. We included articles in which pepsin was studied in LPR patients (clinically suspected or with confirmed diagnosis). Studies with no control group, comparison group, and/or a sample size lower than 20 patients were excluded. Results Twelve studies were included. All included studies, with the exception of 2, found statistically significant differences for pepsin in cases compared with healthy controls. Conclusion Pepsin might be a reliable marker in LPR patients, although questions remain about optimal timing, location, nature, and threshold values for pepsin testing. Future investigations are necessary to clarify the best method to use pepsin in the diagnostic process of LPR.
- Published
- 2017
- Full Text
- View/download PDF